Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV
| Image |  |
|---|---|
| Description | scientific article published on 13 June 2021 |
| Author/s |
author: Vicente Boix Mar Masiá Carolynne Schwarze-Zander François Raffi Jose R. Arribas |
| Publication date | June 13, 2021 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |